$SURNF News
Last published 6mo ago
- 6mo agoSURNFNetworkNews Audio Announces Audio Press Release (APR) Discussing Overcoming Limitations on First-Generation GLP-1 Drug TherapiesGlobeNewswireAUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled "The Next Generation of the GLP-1 Revolution Is Already Underway," featuring SureNano Science
- 6mo agoSURNFSureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel PeptideGlobeNewswireDisseminated on behalf of SureNano Science Ltd. (CSE:SURE) (OTCQB:SURNF) and may include paid advertising. NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- SureNano Science Ltd. (CSE:SURE) (OTCQB:SURNF)
- 6mo agoABBVALTMRKSURNF+1Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market OpportunitiesGlobeNewswireAUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world today, contributing
- 6mo agoSURNFSureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 PlatformGlobeNewswireDisseminated on behalf of SureNano Science Ltd. (CSE:SURE) (OTCQB:SURNF) and may include paid advertising. NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- SureNano Science Ltd. (CSE:SURE) (OTCQB:SURNF)
- 6mo agoAMGNLLYNVOPFE+1The Next Generation of the GLP-1 Revolution Is Already UnderwayGlobeNewswireAUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide, driving rising rates of